One study [40] found that elevated FGF23 correlated with hypervolemia in patients on hemodialysis, although another study [41] reported that FGF23, albeit correlating with volume status in patients on hemodialysis, was not reduced by the hemodialysis. The gene discussed is FGF23; the disease is Hypervolemia.